CVC, GBL Offer to Acquire Italy’s Recordati in $12 Billion Deal

CVC Capital Partners Plc and Groupe Bruxelles Lambert offered to buy Recordati SpA in a deal valuing the Italian drugmaker at more than $12 billion, which would be one of...

By Flavia Rotondi, Manuel Baigorri · Bloomberg Markets

CVC Capital Partners Plc and Groupe Bruxelles Lambert offered to buy Recordati SpA in a deal valuing the Italian drugmaker at more than $12 billion, which would be one of the biggest healthcare deals in Europe this year.